https://www.selleckchem.com/products/tpx-0046.html
77 vs. 0.61 events/patient-year; HR 0.81, 95% CI 0.67-0.97, P=0.03) and a cardiac-related ED visit by 28% (0.48 vs. 0.34 events/patient-year; HR 0.72, 95% CI 0.55-0.93, P=0.01). There was also a 51% decrease (SE=1.41, 95% CI 2.79-8.38days, P0.001) and 62% decrease (SE=1.24, 95% CI 3.35-8.22days, P0.001) in TLOS and CLOS, respectively. A dual platform RPM program for HF using structured education, RPM-capable devices, and alert-specific medication titration reduces the likelihood of experiencing a cardiac hospitalization and car
Like
Comment
Share
